Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.

CONCLUSIONS: Predicting residual lesions after preoperative chemotherapy by using MRI and US is a reasonable strategy. However, current methods are inadequate for identifying patients who can omit surgery; therefore, a new strategy for detecting small tumors in these patients is needed.
PMID: 29619758 [PubMed - as supplied by publisher]

Source: Breast Cancer - April 4, 2018 Category: Cancer & Oncology Authors: Iwase M, Sawaki M, Hattori M, Yoshimura A, Ishiguro J, Kotani H, Gondo N, Adachi Y, Kataoka A, Onishi S, Sugino K, Iwata H Tags: Breast Cancer Source Type: research